Page last updated: 2024-11-05

zinc chloride and Leishmaniasis, Cutaneous

zinc chloride has been researched along with Leishmaniasis, Cutaneous in 1 studies

zinc chloride: RN given refers to parent cpd
zinc dichloride : A compound of zinc and chloride ions in the ratio 1:2. It exists in four crystalline forms, in each of which the Zn(2+) ions are trigonal planar coordinated to four chloride ions.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research Excerpts

ExcerptRelevanceReference
"Disulfiram has primarily been used to treat alcoholism."1.42Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions. ( Melby, PC; Peniche, AG; Renslo, AR; Travi, BL, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peniche, AG1
Renslo, AR1
Melby, PC1
Travi, BL1

Other Studies

1 other study available for zinc chloride and Leishmaniasis, Cutaneous

ArticleYear
Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Animals; Cations, Divalent; Cell Line; Chlorides; Disulfiram; Dose-Response Relationship, Drug; Drug

2015